Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jack, C. R.
Right arrow Articles by Petersen, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jack, C. R., Jr.
Right arrow Articles by Petersen, R. C.
Related Collections
Right arrow MRI
Right arrow Volumetric MRI
Right arrow Alzheimer's disease
NEUROLOGY 2004;62:591-600
© 2004 American Academy of Neurology

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

C. R. Jack, Jr., MD, M. M. Shiung, BA, J. L. Gunter, PhD, P. C. O’Brien, PhD, S. D. Weigand, MS, D. S. Knopman, MD, B. F. Boeve, MD, R. J. Ivnik, MD, G. E. Smith, PhD, R. H. Cha, MS, E. G. Tangalos, MD and R. C. Petersen, PhD MD

From the Departments of Diagnostic Radiology and MR Research Laboratory (Drs. Jack and Gunter, M.M. Shiung), Neurology (Drs. Knopman, Boeve, and Petersen), Health Sciences Research (Dr. O’Brien, S.D. Weigand and R.H. Cha), Psychiatry and Psychology (Drs. Ivnik and Smith), and Internal Medicine (Dr. Tangalos), Mayo Clinic and Foundation, Rochester, MN.

Address correspondence and reprint requests to Dr. C.R. Jack, Jr., Diagnostic Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; e-mail: jack.clifford{at}mayo.edu

Objective: To correlate different methods of measuring rates of brain atrophy from serial MRI with corresponding clinical change in normal elderly subjects, patients with mild cognitive impairment (MCI), and patients with probable Alzheimer disease (AD).

Methods: One hundred sixty subjects were recruited from the Mayo Clinic Alzheimer’s Disease Research Center and Alzheimer’s Disease Patient Registry Studies. At baseline, 55 subjects were cognitively normal, 41 met criteria for MCI, and 64 met criteria for AD. Each subject underwent an MRI examination of the brain at the time of the baseline clinical assessment and then again at the time of a follow-up clinical assessment, 1 to 5 years later. The annualized changes in volume of four structures were measured from the serial MRI studies: hippocampus, entorhinal cortex, whole brain, and ventricle. Rates of change on several cognitive tests/rating scales were also assessed. Subjects who were classified as normal or MCI at baseline could either remain stable or convert to a lower-functioning group. AD subjects were dichotomized into slow vs fast progressors.

Results: All four atrophy rates were greater among normal subjects who converted to MCI or AD than among those who remained stable, greater among MCI subjects who converted to AD than among those who remained stable, and greater among fast than slow AD progressors. In general, atrophy on MRI was detected more consistently than decline on specific cognitive tests/rating scales. With one exception, no differences were found among the four MRI rate measures in the strength of the correlation with clinical deterioration at different stages of the disease.

Conclusions: These data support the use of rates of change from serial MRI studies in addition to standard clinical/psychometric measures as surrogate markers of disease progression in AD. Estimated sample sizes required to power a therapeutic trial in MCI were an order of magnitude less for MRI than for change measures based on cognitive tests/rating scales.


Received March 10, 2003. Accepted in final form October 28, 2003.




This article has been cited by other articles:


Home page
BrainHome page
J. Molano, B. Boeve, T. Ferman, G. Smith, J. Parisi, D. Dickson, D. Knopman, N. Graff-Radford, Y. Geda, J. Lucas, et al.
Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinicopathological study
Brain, November 4, 2009; (2009) awp280v1.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. S. Knopman, C. R. Jack Jr, J. H. Kramer, B. F. Boeve, R. J. Caselli, N. R. Graff-Radford, M. F. Mendez, B. L. Miller, and N. D. Mercaldo
Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year
Neurology, May 26, 2009; 72(21): 1843 - 1849.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. R. Jack Jr, V. J. Lowe, S. D. Weigand, H. J. Wiste, M. L. Senjem, D. S. Knopman, M. M. Shiung, J. L. Gunter, B. F. Boeve, B. J. Kemp, et al.
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
Brain, May 1, 2009; 132(5): 1355 - 1365.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
N. Schuff, N. Woerner, L. Boreta, T. Kornfield, L. M. Shaw, J. Q. Trojanowski, P. M. Thompson, C. R. Jack Jr, M. W. Weiner, and the Alzheimer's; Disease Neuroimaging Initiative
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers
Brain, April 1, 2009; 132(4): 1067 - 1077.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
L. K. McEvoy, C. Fennema-Notestine, J. C. Roddey, D. J. Hagler Jr, D. Holland, D. S. Karow, C. J. Pung, J. B. Brewer, and A. M. Dale
Alzheimer Disease: Quantitative Structural Neuroimaging for Detection and Prediction of Clinical and Structural Changes in Mild Cognitive Impairment
Radiology, April 1, 2009; 251(1): 195 - 205.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. A. Rottenberg
Thin skin: The cortical signature of prodromal AD?
Neurology, March 24, 2009; 72(12): 1038 - 1039.
[Full Text] [PDF]


Home page
BrainHome page
S. Kloppel, C. M. Stonnington, J. Barnes, F. Chen, C. Chu, C. D. Good, I. Mader, L. A. Mitchell, A. C. Patel, C. C. Roberts, et al.
Accuracy of dementia diagnosis--a direct comparison between radiologists and a computerized method
Brain, November 1, 2008; 131(11): 2969 - 2974.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. S. Desikan, B. Fischl, H. J. Cabral, T. L. Kemper, C.R.G. Guttmann, D. Blacker, B. T. Hyman, M. S. Albert, and R. J. Killiany
MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD
Neurology, September 9, 2008; 71(11): 819 - 825.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. M. Brickman, L. S. Honig, N. Scarmeas, O. Tatarina, L. Sanders, M. S. Albert, J. Brandt, D. Blacker, and Y. Stern
Measuring Cerebral Atrophy and White Matter Hyperintensity Burden to Predict the Rate of Cognitive Decline in Alzheimer Disease
Arch Neurol, September 1, 2008; 65(9): 1202 - 1208.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. M. Nestor, R. Rupsingh, M. Borrie, M. Smith, V. Accomazzi, J. L. Wells, J. Fogarty, R. Bartha, and the Alzheimer's Disease Neuroimaging Initiative
Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database
Brain, September 1, 2008; 131(9): 2443 - 2454.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. D. Sluimer, W. M. van der Flier, G. B. Karas, N. C. Fox, P. Scheltens, F. Barkhof, and H. Vrenken
Whole-Brain Atrophy Rate and Cognitive Decline: Longitudinal MR Study of Memory Clinic Patients
Radiology, August 1, 2008; 248(2): 590 - 598.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Kinkingnehun, M. Sarazin, S. Lehericy, E. Guichart-Gomez, T. Hergueta, and B. Dubois
VBM anticipates the rate of progression of Alzheimer disease: A 3-year longitudinal study
Neurology, June 3, 2008; 70(23): 2201 - 2211.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. D. Sluimer, H. Vrenken, M. A. Blankenstein, N. C. Fox, P. Scheltens, F. Barkhof, and W. M. van der Flier
Whole-brain atrophy rate in Alzheimer disease: Identifying fast progressors
Neurology, May 6, 2008; 70(19_Part_2): 1836 - 1841.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. R. Jack Jr, S. D. Weigand, M. M. Shiung, S. A. Przybelski, P. C. O'Brien, J. L. Gunter, D. S. Knopman, B. F. Boeve, G. E. Smith, and R. C. Petersen
Atrophy rates accelerate in amnestic mild cognitive impairment
Neurology, May 6, 2008; 70(19_Part_2): 1740 - 1752.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. S. Liang, E. M. Reiman, J. Valla, T. Dunckley, T. G. Beach, A. Grover, T. L. Niedzielko, L. E. Schneider, D. Mastroeni, R. Caselli, et al.
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons
PNAS, March 18, 2008; 105(11): 4441 - 4446.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Kloppel, C. M. Stonnington, C. Chu, B. Draganski, R. I. Scahill, J. D. Rohrer, N. C. Fox, C. R. Jack Jr, J. Ashburner, and R. S. J. Frackowiak
Automatic classification of MR scans in Alzheimer's disease
Brain, March 1, 2008; 131(3): 681 - 689.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. S. Fleisher, S. Sun, C. Taylor, C. P. Ward, A. C. Gamst, R. C. Petersen, C. R. Jack Jr, P. S. Aisen, L. J. Thal, and For the Alzheimer's Disease Cooperative Study
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment
Neurology, January 15, 2008; 70(3): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. E. Smith, S. Egorova, D. Blacker, R. J. Killiany, A. Muzikansky, B. C. Dickerson, R. E. Tanzi, M. S. Albert, S. M. Greenberg, and C. R. G. Guttmann
Magnetic Resonance Imaging White Matter Hyperintensities and Brain Volume in the Prediction of Mild Cognitive Impairment and Dementia
Arch Neurol, January 1, 2008; 65(1): 94 - 100.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. F. Fotenos, M. A. Mintun, A. Z. Snyder, J. C. Morris, and R. L. Buckner
Brain Volume Decline in Aging: Evidence for a Relation Between Socioeconomic Status, Preclinical Alzheimer Disease, and Reserve
Arch Neurol, January 1, 2008; 65(1): 113 - 120.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
P M THOMPSON and L G APOSTOLOVA
Computational anatomical methods as applied to ageing and dementia
Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S78 - S91.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
R I SCAHILL and N C FOX
Longitudinal imaging in dementia
Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S92 - S98.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
N SCHUFF and X P ZHU
Imaging of mild cognitive impairment and early dementia
Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S109 - S114.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. A. van de Pol, W. M. van der Flier, E.S.C. Korf, N. C. Fox, F. Barkhof, and P. Scheltens
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment
Neurology, October 9, 2007; 69(15): 1491 - 1497.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. G. Apostolova, C. A. Steiner, G. G. Akopyan, R. A. Dutton, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson
Three-Dimensional Gray Matter Atrophy Mapping in Mild Cognitive Impairment and Mild Alzheimer Disease
Arch Neurol, October 1, 2007; 64(10): 1489 - 1495.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. L. Diamond, S. Miller, B. C. Dickerson, A. Atri, K. DePeau, E. Fenstermacher, M. Pihlajamaki, K. Celone, S. Salisbury, M. Gregas, et al.
Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease
Neurology, September 25, 2007; 69(13): 1331 - 1341.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. L. Whitwell, S. A. Przybelski, S. D. Weigand, D. S. Knopman, B. F. Boeve, R. C. Petersen, and C. R. Jack Jr
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease
Brain, July 1, 2007; 130(7): 1777 - 1786.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. Mosconi, W. H. Tsui, A. Pupi, S. De Santi, A. Drzezga, S. Minoshima, and M. J. de Leon
18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease
J. Nucl. Med., July 1, 2007; 48(7): 1129 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
B.H. Ridha, M.R. Symms, D.J. Tozer, K.C. Stockton, C. Frost, M.M. Siddique, E.B. Lewis, D.G. MacManus, P.A. Boulby, G.J. Barker, et al.
Magnetization Transfer Ratio in Alzheimer Disease: Comparison with Volumetric Measurements
AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 965 - 970.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. L. Whitwell, C. R. Jack Jr, J. E. Parisi, D. S. Knopman, B. F. Boeve, R. C. Petersen, T. J. Ferman, D. W. Dickson, and K. A. Josephs
Rates of cerebral atrophy differ in different degenerative pathologies
Brain, April 1, 2007; 130(4): 1148 - 1158.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. L. Jefferson, J. M. Massaro, P. A. Wolf, S. Seshadri, R. Au, R. S. Vasan, M. G. Larson, J. B. Meigs, J. F. Keaney Jr, I. Lipinska, et al.
Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study
Neurology, March 27, 2007; 68(13): 1032 - 1038.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. P. Devanand, G. Pradhaban, X. Liu, A. Khandji, S. De Santi, S. Segal, H. Rusinek, G. H. Pelton, L. S. Honig, R. Mayeux, et al.
Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease
Neurology, March 13, 2007; 68(11): 828 - 836.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. Mosconi, S. Sorbi, M. J. de Leon, Y. Li, B. Nacmias, P. S. Myoung, W. Tsui, A. Ginestroni, V. Bessi, M. Fayyazz, et al.
Hypometabolism Exceeds Atrophy in Presymptomatic Early-Onset Familial Alzheimer's Disease
J. Nucl. Med., November 1, 2006; 47(11): 1778 - 1786.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. G. Apostolova, I. D. Dinov, R. A. Dutton, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease
Brain, November 1, 2006; 129(11): 2867 - 2873.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S E Rose, K L McMahon, A L Janke, B O'Dowd, G de Zubicaray, M W Strudwick, and J B Chalk
Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment
J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1122 - 1128.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. G. Apostolova, R. A. Dutton, I. D. Dinov, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson
Conversion of Mild Cognitive Impairment to Alzheimer Disease Predicted by Hippocampal Atrophy Maps
Arch Neurol, May 1, 2006; 63(5): 693 - 699.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
D. C. Steffens, E. Otey, G. S. Alexopoulos, M. A. Butters, B. Cuthbert, M. Ganguli, Y. E. Geda, H. C. Hendrie, R. R. Krishnan, A. Kumar, et al.
Perspectives on Depression, Mild Cognitive Impairment, and Cognitive Decline
Arch Gen Psychiatry, February 1, 2006; 63(2): 130 - 138.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. R. Jack Jr, M. M. Shiung, S. D. Weigand, P. C. O'Brien, J. L. Gunter, B. F. Boeve, D. S. Knopman, G. E. Smith, R. J. Ivnik, E. G. Tangalos, et al.
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI
Neurology, October 25, 2005; 65(8): 1227 - 1231.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. L. Buckner, A. Z. Snyder, B. J. Shannon, G. LaRossa, R. Sachs, A. F. Fotenos, Y. I. Sheline, W. E. Klunk, C. A. Mathis, J. C. Morris, et al.
Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
J. Neurosci., August 24, 2005; 25(34): 7709 - 7717.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Mungas, D. Harvey, B. R. Reed, W. J. Jagust, C. DeCarli, L. Beckett, W. J. Mack, J. H. Kramer, M. W. Weiner, N. Schuff, et al.
Longitudinal volumetric MRI change and rate of cognitive decline
Neurology, August 23, 2005; 65(4): 565 - 571.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. M. Schott, S. L. Price, C. Frost, J. L. Whitwell, M. N. Rossor, and N. C. Fox
Measuring atrophy in Alzheimer disease: A serial MRI study over 6 and 12 months
Neurology, July 12, 2005; 65(1): 119 - 124.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Enzinger, F. Fazekas, P. M. Matthews, S. Ropele, H. Schmidt, S. Smith, and R. Schmidt
Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects
Neurology, May 24, 2005; 64(10): 1704 - 1711.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. R. Stoub, M. Bulgakova, S. Leurgans, D. A. Bennett, D. Fleischman, D. A. Turner, and L. deToledo-Morrell
MRI predictors of risk of incident Alzheimer disease: A longitudinal study
Neurology, May 10, 2005; 64(9): 1520 - 1524.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. C. Fox, R. S. Black, S. Gilman, M. N. Rossor, S. G. Griffith, L. Jenkins, M. Koller, and for the AN1792(QS-21)-201 Study Team
Effects of A{beta} immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
Neurology, May 10, 2005; 64(9): 1563 - 1572.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. F. Fotenos, A. Z. Snyder, L. E. Girton, J. C. Morris, and R. L. Buckner
Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD
Neurology, March 22, 2005; 64(6): 1032 - 1039.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. L. Chao, N. Schuff, J. H. Kramer, A. T. Du, A. A. Capizzano, J. O'Neill, O. M. Wolkowitz, W. J. Jagust, H. C. Chui, B. L. Miller, et al.
Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients
Neurology, January 25, 2005; 64(2): 282 - 289.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.